Related Experiment Video
Updated: Feb 22, 2026
07:23
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
1.2K
Long Noncoding RNAs in Diabetes and Diabetic Complications
1Department of Diabetes Complications and Metabolism, Diabetes and Metabolic Research Institute, Beckman Research Institute of City of Hope , Duarte, California.
Antioxidants & Redox Signaling
|September 23, 2017
Summary
Long noncoding RNAs (lncRNAs) are key regulators in diabetes complications. Further research into lncRNAs could lead to new therapeutics and early detection biomarkers for diabetic patients.
Area of Science:
- Molecular Biology
- Genetics
- Endocrinology
Background:
- Diabetes mellitus accelerates vascular complications, increasing morbidity and mortality.
- Understanding molecular mechanisms driving these complications is crucial for developing effective therapeutics.
- Long noncoding RNAs (lncRNAs) are emerging as critical regulators of gene expression and cellular function.
Purpose of the Study:
- To explore the role of lncRNAs in the development and progression of diabetic complications.
- To investigate how lncRNAs are regulated by hyperglycemia and influence diabetes-related pathways.
- To identify potential therapeutic targets and biomarkers among dysregulated lncRNAs.
Main Methods:
- Analysis of lncRNA expression in the context of hyperglycemia.
- Investigating the regulatory functions of lncRNAs in cellular pathways relevant to diabetic complications.
- Reviewing existing literature on lncRNA involvement in diabetes.
Main Results:
- lncRNAs are responsive to hyperglycemia.
- lncRNAs are involved in regulating genes and pathways associated with diabetic complications.
- Dysregulation of lncRNAs contributes to the pathogenesis of diabetic complications.
Conclusions:
- lncRNAs play a significant role in the molecular mechanisms underlying diabetic complications.
- Targeting lncRNAs or using them as biomarkers holds promise for improved diabetes treatment and patient outcomes.
- Further research is needed to fully elucidate lncRNA function and therapeutic potential in diabetes.
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
10.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K
02:39lncRNA - Long Non-coding RNAs
3.7K
3.7K
01:20Types of RNA
10.0K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
10.0K
01:23Types of RNA
73.3K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
73.3K
01:20Pathophysiology of Diabetes
3.9K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
01:15Diabetes: Symptoms, Diagnosis, and Complications
2.5K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.5K